CX3CL1 and neurodegenerative disease: Since the over-activation of the kinase has been reported to be a key factor in many neurodegenerative diseases in which some of the alterations show a temporal pattern [28], we decided to evaluate fractalkine levels in 3-month-old and 13-month-old mice.